Valproate-induced parkinsonism in epilepsy patient - A case report

Acta Medica Bulgarica

Volumn 35, Issue 1, 2008, Pages 38-42

  Maximov, K G ^a   Maximov, G K ^a  

^a MILITARY MEDICAL ACADEMY   (Bulgaria)

Author keywords

Epilepsy; Parkinsonism; Valproate

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; VALPROIC ACID;

AGED; ARTICLE; CASE REPORT; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; ELECTROENCEPHALOGRAM; EPILEPTIC DISCHARGE; GRAND MAL EPILEPSY; HUMAN; LOW DRUG DOSE; MALE; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM;

EID: 56349094281     PISSN: 03241750     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Alvarez-Gomez, M. J. et al. Parkinsonian syndrome in childhood after sodium valproate administration. - Clin. Neuropharmacol., 16, 1993, No 3, 451-455.
2. Armon, C. et al. Reversible parkinsonism and cognitive impairemt with chronic valproate use. - Neurology, 47, 1996, No 3, 626-635.
3. Easterford, K. et al. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. - Neurology, 62, 2004, 1435-1437.
4. Felz, P. Pharmacological evidence about nigro-striatal inhibition related to intrinsic GABA in the caudat nucleus deprived of dopaminergic synaptic activity. - Appl. Neurophysiol., 42, 1979, 47.
5. Gale, K. Role of the substantia nigra in GABA-mediated anticonvulsant action. - In: Advances in Neurology - Basic Mechanisms of Epilepsy, Molecular and Cellular Approach. A. V. Delgado-Escueta, A. A. Ward, D. M. Woodbury, R. J. Porter, eds. New York, Raven Press, 1986, 343-363.
6. Jamora D. et al. Valproate-induced parkinsonism in epilepsy patients. - Mov. Disord., 22, 2007, No 1, 130-133. J
7. Masmoudi, K. et al. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. - Pharmacopsychiatry, 39, 2006, No- 1, 9-12.
8. Maximov, K. [Epileptic seizures: clinic and treatment.] Sofia, ARSO, 2002. (in Bulgarian)
9. Maximov, K. [Drug-Resistent Epilepsies: clinical formes, differential diagnosis and treatment.] Sofia, STENO, 2004. (in Bulgarian)
10. Onofrj, M., A. Tomas et C. Paci C. Reversible parkinsonism induced by prolonged treatment with valproate. - J. Neurol., 245, 1998, No 12, 794-796.
11. Park-Matsumoto, Y. C. et T. Tazawa. Valproate-induced parkinsonism. - No To Shinkei, 50, 1998, No 1, 81-84.
12. Petrov, I. Association of patients with parkinsonism and epilepsy with EEG changes. - Prilozi, 27, 2006, No 1, 107-112.
13. Ristic, A. J. et al. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. - Epilepsia, 47, 2006, No 12, 2183-2185.
14. Rosenberg, G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? - Cell. Mol. Life Sci., 64, 2007, 2090-2103.
15. Sasso, E. et al. Reversible Valproate-induced extrapyramidal disorders. - Epilepsia, 35, 1994, No 2, 391-393.
16. Shorvon, S. Handbook of epilepsy treatment. N. Y., Blackwell Science, 2000.
17. Van der Zwan, A. Jr. Transient Parkinson syndrome and tremor caused by the use of sodium valproate. - Ned. Tijdschr. Geneeskd., 133, 1989, No 24, 1230-1232.